The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

In this study, those who had the Zostavax vaccine had a 3.5% point reduction in a new dementia diagnosis over seven years, ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...